ISDA

Deposition Date 1990-11-06

Release Date 1992-04-15

Last Version Date 2024-02-14

Entry Detail

PDB ID:

9HVP

Keywords:

HYDROLASE/HYDROLASE INHIBITOR

Title:

Design, activity and 2.8 Angstroms crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

Biological Source:

Source Organism:

Human immunodeficiency virus 1 (Taxon ID: 11676)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.80 Å

R-Value Work:

0.17

Space Group:

P 61

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:HIV-1 Protease
Chain IDs:A, B
Chain Length:99
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1

UniProt ID:P12497 Pfam ID:PF00077

Ligand Molecules

0E9

Peptide-like Molecules

PRD_000256

Primary Citation

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.

Erickson, J, Neidhart, D.J, VanDrie, J, Kempf, D.J, Wang, X.C, Norbeck, D.W, Plattner, J.J, Rittenhouse, J.W, Turon, M, Wideburg, N.Show

Science 249 527 533 (1990)

PMID: 2200122

Abstact

A two-fold (C2) symmetric inhibitor of the protease of human immunodeficiency virus type-1 (HIV-1) has been designed on the basis of the three-dimensional symmetry of the enzyme active site. The symmetric molecule inhibited both protease activity and acute HIV-1 infection in vitro, was at least 10,000-fold more potent against HIV-1 protease than against related enzymes, and appeared to be stable to degradative enzymes. The 2.8 angstrom crystal structure of the inhibitor-enzyme complex demonstrated that the inhibitor binds to the enzyme in a highly symmetric fashion.

Legend

Protein

Chemical

Disease

Primary Citation of related structures